the study will be conducted to compare the analgesic effects and block characteristics of intrathecal hyperbaric levobupivacaine and hyperbaric ropivacaine in elective caesarean sections.

comparison of intrathecal hyperbaric levobupivacaine and hyperbaric ropivacaine in elective caesarean section: A randomized controlled double blinded study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070609

Enrollment

100

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: INTRATHECAL BLOCK: Upon entering the operating room, standard monitoring devices including noninvasive blood pressure, pulse oximetry, electrocardiography, and temperature will be initi

Eligibility

Inclusion criteria

Inclusion criteria: 1.Elective caesarean delivery, having a gestational age of more than 37 weeks, 2.ASA Class I or II. 3.BMI of 18-30

Exclusion criteria

Exclusion criteria: 1.Refuse regional anaesthesia 2.Individuals with spinal deformity or known hypersensitivity to local anaesthetics 3.Those with placental or fetal abnormalities 4.Individuals with a body weight exceeding 100 kg, 5.Individuals with extreme heights (less than 150 cm or more than 180 cm) 6.Individuals with gestational or pregnancy-induced hypertension,

Design outcomes

Primary

Measure	Time frame
1.To compare onset, regression and duration of sensory block between the groups 2.To compare onset, regression and duration of motor block between the groups 3.To compare duration of analgesisa between the groupsTimepoint: 24hrs	—

Secondary

Measure	Time frame
To compare hemodynamic effects between the groupsTimepoint: 24 hrs	—

Countries

India

Contacts

Public ContactSurendra Kumar Jangid

All India Institute of Medical Sciences, raebareli

dr.skjangid@gmail.com8560919243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026